Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Recruiting · NCT04925375 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease | common variable immunodeficiency, immune system disorder, inborn error of immunity, interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-07-22 | NCT04925375 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Children's Hospital Medical Center, Cincinnati | 229 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Duke University Health System | Durham | United States | 31 |
| Lahey Hospital and Medical Center | Burlington | United States | 63 |
| Mayo Clinic | Rochester | United States | 68 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of South Florida | Tampa | United States | 33 |